Tranexamic Acid
2018-001
Phase 3 small_molecule completed
Quick answer
Tranexamic Acid for Hemorrhagic Shock is a Phase 3 program (small_molecule) at ARROWHEAD PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ARROWHEAD PHARMACEUTICALS, INC.
- Indication
- Hemorrhagic Shock
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed